Astegolimab

astegolimab · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Astegolimab, covering 2025-01-30 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease [Phase 3]